Active substance

Results for the substance ocriplasmin

1 result

About this active substance

Ocriplasmin is an enzyme used in the treatment of symptomatic vitreomacular adhesion, an eye condition that can affect vision. It works by dissolving proteins that bind the vitreous body to the retina, reducing traction.

The medication is administered via intravitreal injection, as directed by an ophthalmologist. It is important for patients to follow the doctor's recommendations and undergo regular check-ups to monitor treatment progress.

Patients should be aware of potential side effects, such as eye pain, blurred vision, or increased intraocular pressure. It is important to inform the doctor of any unusual symptoms.

Common side effects include eye pain, blurred vision, and increased intraocular pressure. In rare cases, severe reactions such as retinal detachment or eye infections may occur. Patients should be informed of these risks before use.